Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Whole-blood transcriptomic signatures induced during immunization by chloroquine prophylaxis and Plasmodium falciparum sporozoites.

Tran TM, Bijker EM, Haks MC, Ottenhoff THM, Visser L, Schats R, Venepally P, Lorenzi H, Crompton PD, Sauerwein RW.

Sci Rep. 2019 Jun 10;9(1):8386. doi: 10.1038/s41598-019-44924-7.

2.

Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis.

Obiero JM, Campo JJ, Scholzen A, Randall A, Bijker EM, Roestenberg M, Hermsen CC, Teng A, Jain A, Davies DH, Sauerwein RW, Felgner PL.

mSphere. 2019 Feb 20;4(1). pii: e00027-19. doi: 10.1128/mSphereDirect.00027-19.

3.

Controlled Human Malaria Infection with Graded Numbers of Plasmodium falciparum NF135.C10- or NF166.C8-Infected Mosquitoes.

Langenberg MCC, Wammes LJ, McCall MBB, Bijker EM, van Gemert GJ, Graumans W, van de Vegte-Bolmer MG, Teelen K, Hermsen CC, Koelewijn R, van Hellemond JJ, van Genderen PJJ, Sauerwein RW.

Am J Trop Med Hyg. 2018 Sep;99(3):709-712. doi: 10.4269/ajtmh.18-0194. Epub 2018 Jul 12.

4.

Mosquito Infectivity and Parasitemia after Controlled Human Malaria Infection.

Walk J, van Gemert GJ, Graumans W, Sauerwein RW, Bijker EM.

Am J Trop Med Hyg. 2018 Jun;98(6):1705-1708. doi: 10.4269/ajtmh.17-0952. Epub 2018 Apr 26.

5.

[A 14-year-old Syrian refugee with neurobrucellosis].

Quaak MSW, Bavelaar HHJ, Berkhout J, Truin GJ, Bijker EM.

Ned Tijdschr Geneeskd. 2017;161:D1663. Dutch.

PMID:
29125076
6.

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.

Walk J, Reuling IJ, Behet MC, Meerstein-Kessel L, Graumans W, van Gemert GJ, Siebelink-Stoter R, van de Vegte-Bolmer M, Janssen T, Teelen K, de Wilt JHW, de Mast Q, van der Ven AJ, Diez Benavente E, Campino S, Clark TG, Huynen MA, Hermsen CC, Bijker EM, Scholzen A, Sauerwein RW.

BMC Med. 2017 Sep 13;15(1):168. doi: 10.1186/s12916-017-0923-4.

7.

Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers.

McCall MBB, Wammes LJ, Langenberg MCC, van Gemert GJ, Walk J, Hermsen CC, Graumans W, Koelewijn R, Franetich JF, Chishimba S, Gerdsen M, Lorthiois A, van de Vegte M, Mazier D, Bijker EM, van Hellemond JJ, van Genderen PJJ, Sauerwein RW.

Sci Transl Med. 2017 Jun 21;9(395). pii: eaag2490. doi: 10.1126/scitranslmed.aag2490.

PMID:
28637923
8.

Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria.

Tran TM, Jones MB, Ongoiba A, Bijker EM, Schats R, Venepally P, Skinner J, Doumbo S, Quinten E, Visser LG, Whalen E, Presnell S, O'Connell EM, Kayentao K, Doumbo OK, Chaussabel D, Lorenzi H, Nutman TB, Ottenhoff TH, Haks MC, Traore B, Kirkness EF, Sauerwein RW, Crompton PD.

Sci Rep. 2016 Aug 10;6:31291. doi: 10.1038/srep31291.

9.

Controlled human malaria infection trials: How tandems of trust and control construct scientific knowledge.

Bijker EM, Sauerwein RW, Bijker WE.

Soc Stud Sci. 2016 Feb;46(1):56-86.

PMID:
26983172
10.

Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial.

Bastiaens GJH, van Meer MPA, Scholzen A, Obiero JM, Vatanshenassan M, van Grinsven T, Sim BKL, Billingsley PF, James ER, Gunasekera A, Bijker EM, van Gemert GJ, van de Vegte-Bolmer M, Graumans W, Hermsen CC, de Mast Q, van der Ven AJAM, Hoffman SL, Sauerwein RW.

Am J Trop Med Hyg. 2016 Mar;94(3):663-673. doi: 10.4269/ajtmh.15-0621. Epub 2015 Dec 28.

11.

Novel approaches to whole sporozoite vaccination against malaria.

Bijker EM, Borrmann S, Kappe SH, Mordmüller B, Sack BK, Khan SM.

Vaccine. 2015 Dec 22;33(52):7462-8. doi: 10.1016/j.vaccine.2015.09.095. Epub 2015 Oct 23. Review.

12.

Ex vivo lymphocyte phenotyping during Plasmodium falciparum sporozoite immunization in humans.

Bijker EM, Schats R, Visser LG, Sauerwein RW, Scholzen A.

Parasite Immunol. 2015 Nov;37(11):590-8. doi: 10.1111/pim.12276.

13.

Plasmodium falciparum Infection of Human Volunteers Activates Monocytes and CD16+ Dendritic Cells and Induces Upregulation of CD16 and CD1c Expression.

Teirlinck AC, Roestenberg M, Bijker EM, Hoffman SL, Sauerwein RW, Scholzen A.

Infect Immun. 2015 Sep;83(9):3732-9. doi: 10.1128/IAI.00473-15. Epub 2015 Jul 13.

14.

Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.

Schats R, Bijker EM, van Gemert GJ, Graumans W, van de Vegte-Bolmer M, van Lieshout L, Haks MC, Hermsen CC, Scholzen A, Visser LG, Sauerwein RW.

PLoS One. 2015 May 1;10(5):e0124243. doi: 10.1371/journal.pone.0124243. eCollection 2015.

15.

Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria.

Bijker EM, Nganou-Makamdop K, van Gemert GJ, Zavala F, Cockburn I, Sauerwein RW.

Malar J. 2015 Mar 26;14:130. doi: 10.1186/s12936-015-0626-2.

16.

Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.

Obiero JM, Shekalaghe S, Hermsen CC, Mpina M, Bijker EM, Roestenberg M, Teelen K, Billingsley PF, Sim BK, James ER, Daubenberger CA, Hoffman SL, Abdulla S, Sauerwein RW, Scholzen A.

Infect Immun. 2015 May;83(5):2185-96. doi: 10.1128/IAI.03069-14. Epub 2015 Mar 16.

17.

Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial.

Bijker EM, Schats R, Obiero JM, Behet MC, van Gemert GJ, van de Vegte-Bolmer M, Graumans W, van Lieshout L, Bastiaens GJ, Teelen K, Hermsen CC, Scholzen A, Visser LG, Sauerwein RW.

PLoS One. 2014 Nov 14;9(11):e112910. doi: 10.1371/journal.pone.0112910. eCollection 2014.

18.

Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.

Nahrendorf W, Scholzen A, Bijker EM, Teirlinck AC, Bastiaens GJ, Schats R, Hermsen CC, Visser LG, Langhorne J, Sauerwein RW.

J Infect Dis. 2014 Dec 15;210(12):1981-90. doi: 10.1093/infdis/jiu354. Epub 2014 Jun 25.

19.

Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.

Bijker EM, Teirlinck AC, Schats R, van Gemert GJ, van de Vegte-Bolmer M, van Lieshout L, IntHout J, Hermsen CC, Scholzen A, Visser LG, Sauerwein RW.

J Infect Dis. 2014 Nov 15;210(10):1605-15. doi: 10.1093/infdis/jiu293. Epub 2014 May 27.

20.

Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.

Behet MC, Foquet L, van Gemert GJ, Bijker EM, Meuleman P, Leroux-Roels G, Hermsen CC, Scholzen A, Sauerwein RW.

Malar J. 2014 Apr 5;13:136. doi: 10.1186/1475-2875-13-136.

21.

BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection.

Scholzen A, Teirlinck AC, Bijker EM, Roestenberg M, Hermsen CC, Hoffman SL, Sauerwein RW.

J Immunol. 2014 Apr 15;192(8):3719-29. doi: 10.4049/jimmunol.1302960. Epub 2014 Mar 19.

22.

Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Bijker EM, Bastiaens GJ, Teirlinck AC, van Gemert GJ, Graumans W, van de Vegte-Bolmer M, Siebelink-Stoter R, Arens T, Teelen K, Nahrendorf W, Remarque EJ, Roeffen W, Jansens A, Zimmerman D, Vos M, van Schaijk BC, Wiersma J, van der Ven AJ, de Mast Q, van Lieshout L, Verweij JJ, Hermsen CC, Scholzen A, Sauerwein RW.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7862-7. doi: 10.1073/pnas.1220360110. Epub 2013 Apr 18.

23.

Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites.

Roestenberg M, Bijker EM, Sim BKL, Billingsley PF, James ER, Bastiaens GJH, Teirlinck AC, Scholzen A, Teelen K, Arens T, van der Ven AJAM, Gunasekera A, Chakravarty S, Velmurugan S, Hermsen CC, Sauerwein RW, Hoffman SL.

Am J Trop Med Hyg. 2013 Jan;88(1):5-13. doi: 10.4269/ajtmh.2012.12-0613. Epub 2012 Nov 13.

24.

[On the way to eradicating malaria].

Bastiaens GJ, Bijker EM, Sauerwein RW.

Ned Tijdschr Geneeskd. 2012;156(5):A4095. Review. Dutch.

PMID:
22296898
25.

Enhancement of naturally acquired immunity against malaria by drug use.

Bijker EM, Sauerwein RW.

J Med Microbiol. 2012 Jul;61(Pt 7):904-10. doi: 10.1099/jmm.0.041277-0. Epub 2012 Jan 26. Review.

PMID:
22282458
26.

Empowering malaria vaccination by drug administration.

Sauerwein RW, Bijker EM, Richie TL.

Curr Opin Immunol. 2010 Jun;22(3):367-73. doi: 10.1016/j.coi.2010.04.001. Epub 2010 Apr 29. Review.

PMID:
20434895
27.

Gut mucosal cell damage in meningococcal sepsis in children: relation with clinical outcome.

Derikx JP, Bijker EM, Vos GD, van Bijnen AA, Heineman E, Buurman WA, van Waardenburg DA.

Crit Care Med. 2010 Jan;38(1):133-7. doi: 10.1097/CCM.0b013e3181b4a5ed.

PMID:
19730255

Supplemental Content

Loading ...
Support Center